HCP BRANDED SOCIAL POST & EMAIL
BESREMi HCP social post
BESREMi is an injectable treatment for Polycythemia vera, a slow-growing blood cancer. Tasked with writing copy for an animated social post targeting hematologist-oncologists, I highlighted a unique feature of BESREMi—that it normalizes all three blood counts, unlike many of its competitors which only focus on one or two.
BESREMi HCP email
For this email, directed at hematologist-oncologists, the primary goal was to convey that low-risk Polycythemia vera patients should be treated proactively. Using a pithy headline, I conveyed that low-risk can, in fact, be urgent. And I included secondary and tertiary messages and CTAs farther down in the email.